FMP

FMP

Enter

RGEN - Repligen Corporation

Financial Summary of Repligen Corporation(RGEN), Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in b

photo-url-https://financialmodelingprep.com/image-stock/RGEN.png

Repligen Corporation

RGEN

NASDAQ

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

125.92 USD

-0.25 (-0.199%)

About

ceo

Mr. Anthony J. Hunt

sector

Healthcare

industry

Medical - Instruments & Supplies

exchange

NASDAQ

Description

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test k...

CIK

0000730272

ISIN

US7599161095

CUSIP

759916109

Address

Building 1

Phone

781 250 0111

Country

US

Employee

1,783

IPO Date

Apr 29, 1986

Summary

CIK

0000730272

Exchange

NASDAQ

Industry

Medical - Instrument...

Sector

Healthcare

CUSIP

759916109

ISIN

US7599161095

Country

US

Price

125.92

Beta

0.95

Volume Avg.

665.95k

Market Cap

7.04B

Shares

-

52-Week

110.45-211.13

DCF

80.18

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

484.31

P/B

-

Website

https://www.repligen.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest RGEN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep